Patient Guide: A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 456 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05242471
Status: ACTIVE_NOT_RECRUITING
Condition: Crohn Disease
Phase: PHASE2

Where You Can Participate

This study is available at 456 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Tucson, Arizona
  • • Little Rock, Arkansas
  • • And 453 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease - Join Clinical Trial NCTNCT05242471

How to Join This Clinical Trial - NCTNCT05242471

Learn how to participate in this PHASE2 trial studying an investigational therapy for Crohn Disease. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Crohn Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Crohn Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05242471 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 456 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: Contact for availability

Clinical Research Site

Tucson, Arizona 85715 - United States

Status: Contact for availability

Clinical Research Site

Little Rock, Arkansas 72205 - United States

Status: Contact for availability

Clinical Research Site

Apple Valley, California 92307 - United States

Status: Contact for availability

Clinical Research Site

Arcadia, California 91006 - United States

Status: Contact for availability

Clinical Research Site

Coronado, California 92118 - United States

Status: Contact for availability

Clinical Research Site

Lancaster, California 93534 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90048 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90095 - United States

Status: Contact for availability

Clinical Research Site

Newport Beach, California 92658 - United States

Status: Contact for availability

And 446 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Crohn Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships